SEC Form 4 · accession 0001213900-16-015411
OptimizeRx Corp · OPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian J Dillon
Officer — SR. VP OF PRODUCT & STRATEGY
Period of report
Jul 28, 2016
Accepted (ET)
Jul 29, 2016 · 5:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001448431
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionF1 | $1.15 | Jul 28, 2016 | A | 100,000 | A | Jul 28, 2017 | Jul 28, 2021 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The option vests 50% on July 28, 2017 and 50% on July 28, 2018.